These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 8599411

  • 1. Treatment of obsessive-compulsive disorder with venlafaxine.
    Grossman R, Hollander E.
    Am J Psychiatry; 1996 Apr; 153(4):576-7. PubMed ID: 8599411
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Venlafaxine treatment of obsessive-compulsive disorder: case reports.
    Marazziti D.
    CNS Spectr; 2003 Jun; 8(6):421-2. PubMed ID: 12858131
    [Abstract] [Full Text] [Related]

  • 5. Venlafaxine in treatment resistant obsessive-compulsive disorder.
    Narayanaswamy JC, Viswanath B, Cherian AV, Math SB, Reddy YC.
    J Neuropsychiatry Clin Neurosci; 2014 Jun; 26(3):E44-5. PubMed ID: 25093787
    [No Abstract] [Full Text] [Related]

  • 6. Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
    Albert U, Aguglia E, Maina G, Bogetto F.
    J Clin Psychiatry; 2002 Nov; 63(11):1004-9. PubMed ID: 12444814
    [Abstract] [Full Text] [Related]

  • 7. Effects of venlafaxine treatment for ADHD in a child.
    Pleak RR, Gormly LJ.
    Am J Psychiatry; 1995 Jul; 152(7):1099. PubMed ID: 7793453
    [No Abstract] [Full Text] [Related]

  • 8. The role of venlafaxine in the treatment of obsessive-compulsive disorder.
    Phelps NJ, Cates ME.
    Ann Pharmacother; 2005 Jan; 39(1):136-40. PubMed ID: 15585743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B, Nestadt G, Allen A, Hollander E.
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of venlafaxine in other psychiatric disorders.
    Ninan PT.
    Depress Anxiety; 2000 Apr; 12 Suppl 1():90-4. PubMed ID: 11098421
    [Abstract] [Full Text] [Related]

  • 16. Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.
    Orenstein H, Raskind MA.
    J Clin Psychiatry; 2010 Jan; 71(1):89-91. PubMed ID: 20129010
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term treatment of geropsychiatric depressed patients with venlafaxine.
    Amore M, Ricci M, Zanardi R, Perez J, Ferrari G.
    J Affect Disord; 1997 Dec; 46(3):293-6. PubMed ID: 9547127
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.